Sponsor study identifier
interventional
20
1 country
1
Study Start
December 13, 2022
Actual (reported)Primary Completion
May 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary spinal cord tumors constitute 2-4% of all central nervous system neoplasms; they are classfied as extradural, intradural extramedullary (IDEM: 65%), and intramedullary The most commonly seen IDEM tumors are schwannomas, neurofibromas, and meningiomas. \[1\] The less frequently encountered IDEM tumors include ependymomas, lipomas, hemangiomas, metastatic deposits, paragangliomas, nerve sheath myxomas, and vascular tumors.\[2\] Spinal cord tumors can cause different signs and symptoms, especially as tumors grow. The tumors may affect spinal cord or the nerve roots, blood vessels or bones of spine. Signs and symptoms may include: Pain at the site of the tumor due to tumor growth Back pain, often radiating to other parts of body Feeling less sensitive to pain, heat and cold Loss of bowel or bladder function Difficulty walking, muscle weakness . MRI is the investigation of choice,however other investigation such CT or X ray are important to ensure stability of the vertebral column and the optimal management is gross total excision for symptomatic lesions.\[3,4\] Over the years, there has been no significant change in the clinical symptoms and pathology of IDEM tumors. However, there have been dramatic improvements in the diagnosis and treatment with the advances of radiological and surgical techniques. Despite advances in operative techniques and neuroimaging, the morbidity associated with the resection of IDEM tumors continues to be significant \[5,6\]. Here, we examined the surgical outcomes of 20 patients with IDEM spinal cord tumors operated in Neurosurgery department at Sohag university Hospital
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 13, 2022
Actual (reported)December 19, 2022
Actual (reported)January 10, 2023
Actual (reported)May 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
May 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
american spinal injury association scale
grading of impairment for motor and sensory functions grade A for complete sensory and motor loss grade E for normal motor and sensory
6 months
visual analogue pain scale
pain scale from zero to ten depend on severity of pain,
6 months
posterior midline approach and total excision for spinal cord tumors
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Sohag University Hospital
Sohag, Egypt
Song KW, Shin SI, Lee JY, Kim GL, Hyun YS, Park DY. Surgical results of intradural extramedullary tumors. Clin Orthop Surg. 2009 Jun;1(2):74-80. doi: 10.4055/cios.2009.1.2.74. Epub 2009 May 27.
Abul-Kasim K, Thurnher MM, McKeever P, Sundgren PC. Intradural spinal tumors: current classification and MRI features. Neuroradiology. 2008 Apr;50(4):301-14. doi: 10.1007/s00234-007-0345-7. Epub 2007 Dec 15.
First Submitted
December 19, 2022
First Posted
January 10, 2023
Study Start
December 13, 2022
Actual (reported)Primary Completion
May 2023
Estimated (date passed)Treatment of Mild and Moderate Cases of Gynaecomastia
Contact the study team to confirm eligibility.
Narayan S, Rege SV, Gupta R. Clinicopathological Study of Intradural Extramedullary Spinal Tumors and Its Correlation With Functional Outcome. Cureus. 2021 Jun 18;13(6):e15733. doi: 10.7759/cureus.15733. eCollection 2021 Jun.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 10, 2023
Record last verified: 2022-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: